Subscribe To
FREQ / Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise
Content Topics
Frequency
Therapeutics
Hearing
Loss
Candidate
Shows
Therapeutics
Improved
Speech
Perception
Stock
FREQ
FREQ News
By Zacks Investment Research
July 17, 2023
Frequency (FREQ) Up 77% on Merger Deal With Korro Bio
Post-merger, Frequency (FREQ) focuses on advancing RNA editing programs. This combined entity is set to operate under the name Korro Bio, which will a more_horizontal
By InvestorPlace
July 14, 2023
Why Is Frequency Therapeutics (FREQ) Stock Up 44% Today?
Frequency Therapeutics (NASDAQ: FREQ ) stock is rocketing higher on Friday following news that it will combine with Korro Bio . This merger plan is d more_horizontal
By Pulse2
February 13, 2023
FREQ Stock: 80.54% Plummet Explanation
The stock price of Frequency Therapeutics Inc (NASDAQ: FREQ) plummeted 80.54% in the most recent trading session. This is why. more_horizontal
By Benzinga
December 9, 2021
Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise
Frequency Therapeutics Inc (NASDAQ: FREQ) shared the results from its FX-322-113 study of FX-322 in severe sensorineural hearing loss (SNHL). The P more_horizontal
By Benzinga
December 9, 2021
Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise
Frequency Therapeutics Inc (NASDAQ: FREQ) shared the results from its FX-322-113 study of FX-322 in severe sensorineural hearing loss (SNHL). The P more_horizontal
By Benzinga
December 9, 2021
Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise
Frequency Therapeutics Inc (NASDAQ: FREQ) shared the results from its FX-322-113 study of FX-322 in severe sensorineural hearing loss (SNHL). The P more_horizontal